2-amino-4,5,6,7-tetrahydrobenzothiazole has been researched along with sotorasib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, JR; Arnhof, H; Böttcher, J; Bröker, J; Gerstberger, T; Gmachl, M; Gmaschitz, G; Gollner, A; Herdeis, L; Kessler, D; Krämer, O; Little, A; Mantoulidis, A; Mayer, M; McConnell, DB; Mischerikow, N; Phan, J; Rudolph, D; Rumpel, K; Savarese, F; Smethurst, C; Sun, Q; Treu, M; W Fesik, S; Waterson, AG; Weinstabl, H; Wunberg, T | 1 |
1 other study(ies) available for 2-amino-4,5,6,7-tetrahydrobenzothiazole and sotorasib
| Article | Year |
|---|---|
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS
Topics: Cysteine; Genes, ras; Humans; Mutation; Neoplasms; Proto-Oncogene Proteins p21(ras) | 2022 |